Prolonged preservation of nerve function in diabetic neuropathy in mice by herpes simplex virus-mediated gene transfer

This publication has 37 references indexed in Scilit:

• HSV-1-mediated NGF delivery delays nociceptive deficits in a genetic model of diabetic neuropathy
  Experimental Neurology, 2006
• Long-Term Neuroprotection Achieved with Latency-Associated Promoter-Driven Herpes Simplex Virus Gene Transfer to the Peripheral Nervous System
  Molecular Therapy, 2005
• Herpes Vector-Mediated Gene Transfer in Treatment of Diseases of the Nervous System
  Annual Review of Microbiology, 2004
• Prolonged biologically active transgene expression driven by HSV LAP2 in brain in vivo
  Molecular Therapy, 2004
• Protective effect of herpes simplex virus-mediated neurotrophin gene transfer in cisplatin neuropathy
  Brain, 2004
• Viral and non-viral gene therapy partially prevents experimental cisplatin-induced neuropathy
  Gene Therapy, 2002
• Continuous Delivery of Neurotrophin 3 by Gene Therapy Has a Neuroprotective Effect in Experimental Models of Diabetic and Acrylamide Neuropathies
  Human Gene Therapy, 2001
• Partial Prevention of Cisplatin-Induced Neuropathy by Electroporation-Mediated Nonviral Gene Transfer
  Human Gene Therapy, 2001
• Neurofilament and tubulin gene expression in progressive experimental diabetes
  Brain, 1999
• Latent Herpes Simplex Virus in Human Trigeminal Ganglia
  New England Journal of Medicine, 1987